prednisolone has been researched along with Adverse Drug Event in 55 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy and safety of yttrium-90 ((90)Y)-ibritumomab tiuxetan consolidation treatment following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) chemotherapy was investigated in patients with limited-stage and bulky diffuse large B-cell lymphoma (DLBCL)." | 9.16 | Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma. ( Chung, JS; Kim, JS; Kim, SJ; Kim, WS; Kwak, JY; Lee, JJ; Oh, SY; Suh, C; Yang, DH, 2012) |
| "The objective of this study was to assess the usefulness of tacrolimus (TAC) for rheumatoid arthritis (RA) patients." | 7.76 | Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis. ( Inoue, E; Kaneko, H; Kitahama, M; Koseki, Y; Momohara, S; Okamoto, H; Taniguchi, A; Yamanaka, H, 2010) |
| "The prednisolone treatment duration was significantly longer in the PIO patient group than in the non-PIO patient group." | 5.72 | Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database. ( Hasegawa, S; Inoue, M; Iwata, M; Maezawa, M; Masuta, M; Matsumoto, K; Nakamura, M; Oura, K; Satake, R; Suzuki, T; Tanaka, M; Uranishi, H; Wakabayashi, W; Yoshida, Y, 2022) |
| "The clinical efficacy and safety of yttrium-90 ((90)Y)-ibritumomab tiuxetan consolidation treatment following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) chemotherapy was investigated in patients with limited-stage and bulky diffuse large B-cell lymphoma (DLBCL)." | 5.16 | Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma. ( Chung, JS; Kim, JS; Kim, SJ; Kim, WS; Kwak, JY; Lee, JJ; Oh, SY; Suh, C; Yang, DH, 2012) |
| "This study highlights the impact short term anti-inflammatory doses of prednisone or prednisolone have on dog behaviour and confirms our hypothesis that by day 14, 90% of dogs experienced one or more behaviour changes, with polyuria and polydipsia most commonly reported." | 4.31 | Perception and usage of short-term prednisone and prednisolone in dogs. ( Gober, M; Hillier, A, 2023) |
| " The patient showed persistent proteinuria and a systemic steroid (prednisolone 50 mg [1 mg/kg]) was started." | 4.02 | IgA vasculitis mimicking drug-induced skin reaction and infectious colitis in an elderly patient: A case report. ( Seo, SY; Yim, SK, 2021) |
| "To evaluate the adverse events profile of oral prednisolone among adult asthma patients in the UK." | 3.88 | Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis. ( Bloechliger, M; Chang, SC; Heaney, LG; Jick, SS; Kuhlbusch, K; Meier, CR; Reinau, D; Spoendlin, J, 2018) |
| "The objective of this study was to assess the usefulness of tacrolimus (TAC) for rheumatoid arthritis (RA) patients." | 3.76 | Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis. ( Inoue, E; Kaneko, H; Kitahama, M; Koseki, Y; Momohara, S; Okamoto, H; Taniguchi, A; Yamanaka, H, 2010) |
| "Metformin thus seems to be a promising drug for preventing metabolic side effects during systemic glucocorticoid treatment." | 2.84 | Metformin prevents metabolic side effects during systemic glucocorticoid treatment. ( Bally, M; Christ-Crain, M; Korbonits, M; Meyer, S; Müller, B; Nigro, N; Pernicova, I; Schuetz, P; Seelig, E; Timper, K, 2017) |
| "Diarrhea is a common clinical feature of inflammatory bowel diseases and may be accompanied by abdominal pain, urgency, and fecal incontinence." | 2.48 | Diarrhea in chronic inflammatory bowel diseases. ( Wenzl, HH, 2012) |
| "Optic neuropathy in uremia is rare." | 2.41 | Optic neuropathy in uremia: an interdisciplinary emergency. ( Berger, O; Eigner, M; Grisold, W; Leithner, C; Winkelmayer, WC, 2001) |
| " Any adverse events that required dose reduction or cessation of hydroxychloroquine, indicating intolerance to the drug, were recorded for up to 26 weeks after initiation of hydroxychloroquine." | 1.91 | Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus. ( Araki, K; Hirata, S; Ishitoku, M; Kohno, H; Masuda, S; Mokuda, S; Oka, N; Sugimoto, T; Watanabe, H; Yorishima, A; Yoshida, Y, 2023) |
| "Prednisolone was significantly correlated with hematophagic histiocytosis (ROR, 1." | 1.72 | Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database. ( Hirai, T; Hosohata, K; Iida, T; Inada, A; Kambara, H; Niinomi, I; Oyama, S; Sano, Y; Uchida, M; Wakabayashi, T, 2022) |
| "The prednisolone treatment duration was significantly longer in the PIO patient group than in the non-PIO patient group." | 1.72 | Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database. ( Hasegawa, S; Inoue, M; Iwata, M; Maezawa, M; Masuta, M; Matsumoto, K; Nakamura, M; Oura, K; Satake, R; Suzuki, T; Tanaka, M; Uranishi, H; Wakabayashi, W; Yoshida, Y, 2022) |
| "We describe the first report of acute eosinophilic pneumonia (AEP), which is known as Th2-associated pulmonary disease, triggered by nivolumab, an anti-PD-1 antibody, in an advanced non-small cell lung cancer patient." | 1.51 | A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient. ( Fujii, K; Ichiyasu, H; Iyama, S; Jodai, T; Kakiuchi, Y; Kimura, T; Saeki, S; Saruwatari, K; Sato, N; Sato, R; Tomita, Y; Yoshida, C, 2019) |
| "While dermatomyositis is often associated with malignancy, several autoimmune diseases like myositis can be caused by immune checkpoint inhibitors." | 1.51 | Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report. ( Arai, J; Fukumura, Y; Imai, M; Kato, J; Kojima, K; Kondo, M; Kurokawa, K; Ohki, T; Seki, M; Shibata, C; Suzuki, A; Tagawa, K; Takagi, K; Toda, N; Yoshida, M, 2019) |
| " To assess the association between steroid dose used for relapse and subsequent outcomes, data of patients with tapered prednisolone (PSL) dosage to <10 mg/day before the first relapse in whom the dose was subsequently increased to ≥10 mg/day were extracted and assigned to the High-PSL or Low-PSL groups, based on the median dose of 20 mg/day." | 1.48 | Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study. ( Ando, M; Kato, S; Katsuno, T; Maruyama, S; Ozeki, T; Tsuboi, N; Yamaguchi, M; Yasuda, Y, 2018) |
| "Oral estramustine 560 mg was given concurrently for five consecutive days during weeks 1 and 2 of each cycle, and prednisolone 10 mg was given every day." | 1.39 | Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer. ( Fujii, R; Hara, I; Inagaki, T; Kohjimoto, Y; Kuramoto, T; Matusmura, N; Nanpo, Y; Nishizawa, S; Sasaki, Y, 2013) |
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| "Neurotoxicity is an unwanted acute side effect of aggressive chemotherapy." | 1.36 | Evidence for acute neurotoxicity after chemotherapy. ( Cornelissen, J; Filippi, M; Giovannoni, G; Hintzen, R; Kappos, L; Kuhle, J; Lowenberg, B; Mondria, T; Petzold, A; Rocca, MA; te Boekhorst, P, 2010) |
| " While many effects on the immune system's components can be found as a result of a drug treatment or chemical exposure, true immunotoxicity occurs when such treatment results in adverse effects or defects in the immune response." | 1.32 | Adequate immunotoxicity testing in drug development. ( Gore, ER; Herzyk, DJ, 2004) |
| " Prednisolone in standard dosage schedule as recommended by WHO is now being widely used in control programmes." | 1.32 | Reactions and their management. ( Ganapati, R; Pai, VV, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (21.82) | 18.7374 |
| 1990's | 3 (5.45) | 18.2507 |
| 2000's | 10 (18.18) | 29.6817 |
| 2010's | 20 (36.36) | 24.3611 |
| 2020's | 10 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Pedersen, JM | 1 |
| Matsson, P | 1 |
| Bergström, CA | 1 |
| Norinder, U | 1 |
| Hoogstraate, J | 1 |
| Artursson, P | 1 |
| Chen, M | 1 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 2 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Yim, SK | 1 |
| Seo, SY | 1 |
| Niinomi, I | 1 |
| Oyama, S | 1 |
| Inada, A | 1 |
| Wakabayashi, T | 1 |
| Hirai, T | 1 |
| Kambara, H | 1 |
| Iida, T | 1 |
| Uchida, M | 1 |
| Sano, Y | 1 |
| Hosohata, K | 1 |
| Yoshida, Y | 4 |
| Oka, N | 3 |
| Yorishima, A | 3 |
| Masuda, S | 3 |
| Ishitoku, M | 3 |
| Araki, K | 3 |
| Kohno, H | 3 |
| Watanabe, H | 3 |
| Sugimoto, T | 3 |
| Mokuda, S | 3 |
| Hirata, S | 3 |
| Wakabayashi, W | 1 |
| Tanaka, M | 1 |
| Matsumoto, K | 1 |
| Satake, R | 1 |
| Inoue, M | 1 |
| Oura, K | 1 |
| Suzuki, T | 1 |
| Iwata, M | 1 |
| Hasegawa, S | 1 |
| Masuta, M | 1 |
| Uranishi, H | 1 |
| Maezawa, M | 1 |
| Nakamura, M | 1 |
| Gober, M | 1 |
| Hillier, A | 1 |
| Dinesh Kumar, J | 1 |
| Geminiganesan, S | 1 |
| Padmanaban, R | 1 |
| Pinnaka, S | 1 |
| Chandrasekar, T | 1 |
| Mozo Cuadrado, M | 1 |
| Tabuenca Del Barrio, L | 1 |
| Compains Silva, E | 1 |
| De Filippo, M | 1 |
| Clark, E | 1 |
| Fillard, A | 1 |
| Diaferio, L | 1 |
| Caimmi, D | 1 |
| Othonos, N | 1 |
| Marjot, T | 1 |
| Woods, C | 1 |
| Hazlehurst, JM | 1 |
| Nikolaou, N | 1 |
| Pofi, R | 1 |
| White, S | 1 |
| Bonaventura, I | 1 |
| Webster, C | 1 |
| Duffy, J | 1 |
| Cornfield, T | 1 |
| Moolla, A | 1 |
| Isidori, AM | 1 |
| Hodson, L | 1 |
| Tomlinson, JW | 1 |
| Ozturk, T | 1 |
| Arikan, G | 1 |
| Oner, H | 1 |
| Hasegawa, Y | 1 |
| Kawai, S | 1 |
| Ota, T | 1 |
| Tsukuda, H | 1 |
| Fukuoka, M | 1 |
| Ngu, S | 1 |
| Shaffrali, F | 1 |
| Bloechliger, M | 1 |
| Reinau, D | 1 |
| Spoendlin, J | 1 |
| Chang, SC | 1 |
| Kuhlbusch, K | 1 |
| Heaney, LG | 1 |
| Jick, SS | 1 |
| Meier, CR | 1 |
| Ozeki, T | 1 |
| Ando, M | 1 |
| Yamaguchi, M | 1 |
| Katsuno, T | 1 |
| Kato, S | 1 |
| Yasuda, Y | 1 |
| Tsuboi, N | 1 |
| Maruyama, S | 1 |
| Gowda, VK | 1 |
| Narayanaswamy, V | 1 |
| Shivappa, SK | 1 |
| Benakappa, N | 1 |
| Benakappa, A | 1 |
| Jodai, T | 1 |
| Yoshida, C | 1 |
| Sato, R | 1 |
| Kakiuchi, Y | 1 |
| Sato, N | 1 |
| Iyama, S | 1 |
| Kimura, T | 1 |
| Saruwatari, K | 1 |
| Saeki, S | 1 |
| Ichiyasu, H | 1 |
| Fujii, K | 1 |
| Tomita, Y | 1 |
| Shibata, C | 1 |
| Kato, J | 1 |
| Toda, N | 1 |
| Imai, M | 1 |
| Fukumura, Y | 1 |
| Arai, J | 1 |
| Kurokawa, K | 1 |
| Kondo, M | 1 |
| Takagi, K | 1 |
| Kojima, K | 1 |
| Ohki, T | 1 |
| Seki, M | 1 |
| Yoshida, M | 1 |
| Suzuki, A | 1 |
| Tagawa, K | 1 |
| Parkins, G | 1 |
| White, B | 1 |
| Seelig, E | 1 |
| Meyer, S | 1 |
| Timper, K | 1 |
| Nigro, N | 1 |
| Bally, M | 1 |
| Pernicova, I | 1 |
| Schuetz, P | 1 |
| Müller, B | 1 |
| Korbonits, M | 1 |
| Christ-Crain, M | 1 |
| Rassy, EE | 1 |
| Assi, T | 1 |
| Rizkallah, J | 1 |
| Kattan, J | 1 |
| Richette, P | 1 |
| Bardin, T | 1 |
| Kitahama, M | 1 |
| Okamoto, H | 1 |
| Koseki, Y | 1 |
| Inoue, E | 1 |
| Kaneko, H | 1 |
| Taniguchi, A | 1 |
| Momohara, S | 1 |
| Yamanaka, H | 1 |
| Lee, SM | 1 |
| Cheng, B | 1 |
| Cheung, YK | 1 |
| Petzold, A | 1 |
| Mondria, T | 1 |
| Kuhle, J | 1 |
| Rocca, MA | 1 |
| Cornelissen, J | 1 |
| te Boekhorst, P | 1 |
| Lowenberg, B | 1 |
| Giovannoni, G | 1 |
| Filippi, M | 1 |
| Kappos, L | 1 |
| Hintzen, R | 1 |
| Yang, DH | 1 |
| Kim, WS | 1 |
| Kim, SJ | 1 |
| Kim, JS | 1 |
| Kwak, JY | 1 |
| Chung, JS | 1 |
| Oh, SY | 1 |
| Suh, C | 1 |
| Lee, JJ | 1 |
| Nishimura, K | 1 |
| Nonomura, N | 1 |
| Hashine, K | 1 |
| Kanayama, HO | 1 |
| Ozono, S | 1 |
| Miura, T | 1 |
| Miki, T | 1 |
| Kakehi, Y | 1 |
| Arai, Y | 1 |
| Ogawa, O | 1 |
| Fujita, R | 1 |
| Nonomura, K | 1 |
| Mizokami, A | 1 |
| Hoshi, S | 1 |
| Akaza, H | 1 |
| Wenzl, HH | 1 |
| Kuramoto, T | 1 |
| Inagaki, T | 1 |
| Fujii, R | 1 |
| Sasaki, Y | 1 |
| Nishizawa, S | 1 |
| Nanpo, Y | 1 |
| Matusmura, N | 1 |
| Kohjimoto, Y | 1 |
| Hara, I | 1 |
| Edwards, SA | 1 |
| Cranfield, T | 1 |
| Clarke, HJ | 1 |
| LACHNIT, V | 1 |
| PANE, A | 3 |
| PEZZULLO, C | 2 |
| TEDESCHI, G | 3 |
| DIGILIO, V | 3 |
| PEZZULA, C | 1 |
| MIKES, A | 1 |
| TODOROVIC, D | 1 |
| Herzyk, DJ | 1 |
| Gore, ER | 1 |
| Ganapati, R | 1 |
| Pai, VV | 1 |
| Shen, YC | 1 |
| Wang, CY | 1 |
| Fong, SC | 1 |
| Tsai, HY | 1 |
| Lee, YF | 1 |
| Iwamoto, T | 1 |
| Hagiwara, K | 1 |
| Kawasaki, H | 1 |
| Murawaki, Y | 1 |
| Chang, YT | 1 |
| Liu, HN | 1 |
| Wong, CK | 1 |
| Davison, AM | 1 |
| Jones, CH | 1 |
| Winkelmayer, WC | 1 |
| Eigner, M | 1 |
| Berger, O | 1 |
| Grisold, W | 1 |
| Leithner, C | 1 |
| Hashimoto, T | 1 |
| Vinokurova, NA | 1 |
| Komakhidze, ME | 1 |
| Akhmeteli, TI | 1 |
| Khundadze, SSh | 1 |
| Dzneladze, LT | 1 |
| Gvasaliia, GN | 1 |
| Rambaldi, M | 1 |
| Russo, R | 1 |
| Iaquinto, G | 1 |
| Agozzino, L | 1 |
| De Cristofano, R | 1 |
| Mukherjee, DK | 1 |
| Mukherjee, K | 1 |
| Belousova, IM | 1 |
| Parsonage, M | 1 |
| Feng, PH | 1 |
| Cheah, PS | 1 |
| Lee, YK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Melanoma, breAst or Lung Cancer Patients With Brain Metastases: the Phase II OPTIMAL Study[NCT04001725] | Phase 2 | 110 participants (Anticipated) | Interventional | 2019-10-15 | Recruiting | ||
| Phase II Study of 90Y-ibritumomab Tiuxetan Treatment as a Consolidation After 6th R-CHOP Chemotherapy in Patients With Limited-stage, Bulky Diffuse Large B Cell Lymphoma[NCT01157988] | Phase 2 | 20 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for prednisolone and Adverse Drug Event
| Article | Year |
|---|---|
Diarrhea in chronic inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections | 2012 |
[Pharmacokinetic and molecular biological approaches to achieve the safety and effective management of drug therapies].
Topics: Anti-Bacterial Agents; Biomarkers; Blood Glucose; Dacarbazine; Diabetes Mellitus; Drug Monitoring; D | 2007 |
[Drug-induced pulmonary infiltration with eosinophilia, eosinophilic pneumonia].
Topics: Aspergillosis, Allergic Bronchopulmonary; Churg-Strauss Syndrome; Drug-Related Side Effects and Adve | 2007 |
[Various problems in therapy and prognosis of drug-induced liver diseases].
Topics: Chemical and Drug Induced Liver Injury; Diet, Fat-Restricted; Drug-Related Side Effects and Adverse | 1995 |
Acute interstitial nephritis in the elderly: a report from the UK MRC Glomerulonephritis Register and a review of the literature.
Topics: Acute Disease; Aged; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infections; Ma | 1998 |
Optic neuropathy in uremia: an interdisciplinary emergency.
Topics: Anti-Inflammatory Agents; Drug-Related Side Effects and Adverse Reactions; Emergency Medical Service | 2001 |
[Erythema exsudativum multiforme (EEM) syndrome, Stevens-Johnson syndrome (SJS)].
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Inf | 2000 |
[Pancreatitis caused by drugs].
Topics: Adult; Azathioprine; Chlorothiazide; Contraceptives, Oral; Drug-Related Side Effects and Adverse Rea | 1977 |
5 trials available for prednisolone and Adverse Drug Event
| Article | Year |
|---|---|
Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids.
Topics: 5-alpha Reductase Inhibitors; Adipose Tissue; Adolescent; Adult; Aged; Disease Progression; Drug Int | 2020 |
Corticotrophin-ACTH in Comparison to Prednisolone in West Syndrome - A Randomized Study.
Topics: Adrenocorticotropic Hormone; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Epil | 2019 |
Metformin prevents metabolic side effects during systemic glucocorticoid treatment.
Topics: Adult; Aged; Anti-Inflammatory Agents; Blood Glucose; Double-Blind Method; Drug-Related Side Effects | 2017 |
Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamid | 2012 |
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug- | 2013 |
42 other studies available for prednisolone and Adverse Drug Event
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Bi | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
IgA vasculitis mimicking drug-induced skin reaction and infectious colitis in an elderly patient: A case report.
Topics: Abdominal Pain; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Diarr | 2021 |
Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database.
Topics: Adverse Drug Reaction Reporting Systems; Arthritis, Juvenile; Databases, Factual; Drug-Related Side | 2022 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy | 2023 |
Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database.
Topics: Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Prednisol | 2022 |
Perception and usage of short-term prednisone and prednisolone in dogs.
Topics: Animals; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Hyperphagia; Perceptio | 2023 |
An Unusual Case of Cardiomyopathy in a Child.
Topics: Cardiomyopathies; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Immunoglobulins; M | 2020 |
Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma.
Topics: Aged; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Epiretinal Membrane; F | 2021 |
Oral corticosteroids and asthma in children: Practical considerations.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Child, Preschoo | 2020 |
Herpetic Keratouveitis following Intravitreal Ranibizumab Injection in a Case with Diabetic Macular Edema.
Topics: Angiogenesis Inhibitors; Antiviral Agents; Diabetic Retinopathy; Drug Therapy, Combination; Drug-Rel | 2021 |
Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review.
Topics: Aged; Antibodies, Monoclonal; Autoantibodies; Blepharoptosis; Carcinoma, Non-Small-Cell Lung; Creati | 2017 |
A case of severe drug reaction secondary to alemtuzumab with successful re-exposure.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Blister; Clinical Trials, Phase III as Topic; | 2017 |
Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Asthma; Case-Control Studies; Cohort Studies; Databas | 2018 |
Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study.
Topics: Blood Proteins; Creatinine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug-Related Si | 2018 |
A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactio | 2019 |
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Topics: Aged; Antineoplastic Agents, Immunological; Dermatomyositis; Diagnosis, Differential; Drug-Related S | 2019 |
DRESS syndrome presenting like septic shock.
Topics: Adult; Diagnosis, Differential; Drug Eruptions; Drug Hypersensitivity Syndrome; Drug-Related Side Ef | 2013 |
Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumab.
Topics: Anemia; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Cytokines; Drug-Related Side Ef | 2017 |
Should prednisolone be first-line therapy for acute gout?
Topics: Acute Disease; Anti-Inflammatory Agents; Colchicine; Drug-Related Side Effects and Adverse Reactions | 2008 |
Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Drug Resistance; Drug Therapy, Combination; Drug-Related Side Effects and Adv | 2010 |
Continual reassessment method with multiple toxicity constraints.
Topics: Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bo | 2011 |
Evidence for acute neurotoxicity after chemotherapy.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Brain; Case-Control Studie | 2010 |
Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, | 2013 |
Atypical presentation of septic arthritis in the immunosuppressed patient.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Diagnosis, Differential; Drainage; Drug-Related | 2002 |
[Therapy of irritant gas poisoning].
Topics: Cardiovascular Agents; Drug-Related Side Effects and Adverse Reactions; Gas Poisoning; Irritants; Ni | 1958 |
[Effects of methylandrostenediol & prednisolone in experimental emetine poisoning; ponderal & survival curves].
Topics: Androgens; Body Weight; Body Weights and Measures; Drug-Related Side Effects and Adverse Reactions; | 1958 |
[Effects of methylandrostenediol & prednisolone in experimental emetine poisoning; effects on the protein picture].
Topics: Androgens; Blood Proteins; Drug-Related Side Effects and Adverse Reactions; Emetine; Humans; Methand | 1958 |
[Effect of methylandrostendiol and prednisolone in experimental emetine poisoning; ECG study].
Topics: Androgens; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Emetine; Prednisolo | 1958 |
[Effect of 6-aminonicotamide on the liver in guinea pigs. Protective effect of nicotamide and of prednisolone. I. Acute intoxication].
Topics: Animals; Drug-Related Side Effects and Adverse Reactions; Guinea Pigs; Liver; Niacin; Nicotinic Acid | 1959 |
Adequate immunotoxicity testing in drug development.
Topics: Animals; Antibody Formation; Azathioprine; Cyclosporine; Drug Evaluation, Preclinical; Drug-Related | 2004 |
Reactions and their management.
Topics: Arthritis; Cicatrix; Clofazimine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Ad | 2004 |
Diffuse lamellar keratitis induced by toxic chemicals after laser in situ keratomileusis.
Topics: Adult; Corneal Stroma; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Hum | 2006 |
Bullous pemphigoid--a report of 86 cases from Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Child; D | 1996 |
[Combined chemotherapy in generalized lymphogranulomatosis].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Drug Therapy, Combination; Drug-Related Side | 1975 |
[Gastrointestinal hemorrhages as a consequence of the side effects of drug substances].
Topics: Aspirin; Blood Volume; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Hem | 1977 |
Ototoxicity of commonly used pharmaceutical preparations.
Topics: Adolescent; Adult; Ampicillin; Antihypertensive Agents; Antineoplastic Agents; Aspirin; Child; Chlor | 1979 |
[Gastrointestinal hemorrhage caused by side effect of drugs].
Topics: Adult; Aged; Aspirin; Butadienes; Drug-Related Side Effects and Adverse Reactions; Female; Humans; I | 1976 |
Epilepsy.
Topics: Adrenocorticotropic Hormone; Carbamazepine; Diazepam; Drug Hypersensitivity; Drug-Related Side Effec | 1974 |
Mortality in systemic lupus erythematosus: a 10-year review.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cerebrospinal Fluid Proteins; Child; Chlorides; Coma; Cyc | 1973 |